Today: 20 May 2026
Lumentum stock price whipsaws 9% as traders brace for Feb. 3 earnings
30 January 2026
1 min read

Lumentum stock price whipsaws 9% as traders brace for Feb. 3 earnings

New York, January 29, 2026, 21:33 EST — Market closed.

  • Lumentum shares fell 0.9% to $381.44 after swinging between $364.19 and $398.16
  • The company set a March 17 investor briefing at OFC 2026 in Los Angeles
  • Investors are positioning for Lumentum’s Feb. 3 quarterly results and outlook

Lumentum Holdings Inc (LITE) shares swung more than 9% on Thursday before closing down 0.9% at $381.44, a choppy finish that kept the stock in play heading into next week’s earnings report.

The timing matters. Investors are re-pricing parts of the AI trade after a bruising day for U.S. tech, and suppliers tied to data-center buildouts are being pulled into that push and pull.

Lumentum added its own checkpoint on Wednesday, saying management will host an investor briefing during the Optical Fiber Communication Conference and Exhibition in Los Angeles on March 17.

The wider tape was not friendly. The Nasdaq slid 0.7% and technology was the weakest of the major S&P sectors as Microsoft sank 10%, reviving doubts about whether soaring AI budgets will pay off quickly. “Microsoft disappointed and there are some genuine concerns that AI investments will eat the software companies’ lunches,” John Praveen, managing director and co-CIO at Paleo Leon, said. Reuters

Lumentum, headquartered in San Jose, makes optical and photonic products used in telecom, enterprise and data-center networks, along with lasers used in manufacturing and sensing applications.

Some investors treat the stock as a read-through on demand for high-speed optical links inside data centers, where buildouts can come in bursts and then pause.

The near-term catalyst is Feb. 3. Lumentum is scheduled to release fiscal second-quarter results after the market closes and host a webcast at 5 p.m. ET, the company said in an earlier notice.

Besides the headline numbers, traders will be listening for guidance that speaks to order timing and customer spending patterns, and for any signs that supply and pricing are tightening in its optical components.

But sentiment can flip fast when investors start debating whether AI is creating winners or just reshuffling budgets. “The market’s kind of in our view pricing a worst-case scenario that software is dead because AI is disrupting the space,” Adam Turnquist, chief technical strategist for LPL Financial, told Reuters. Reuters

For Lumentum, any hint that customers are stretching deployments or smoothing orders could hit the stock, especially after a session like Thursday.

Into Friday, traders will watch whether Lumentum can stay anchored after Thursday’s $364-to-$398 swing. Next week, the focus tightens to Feb. 3 — and then to what management chooses to put on the table at OFC in March.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Snowflake stock slides nearly 8% in software rout; traders brace for next catalyst
Previous Story

Snowflake stock slides nearly 8% in software rout; traders brace for next catalyst

GSK share price dips in London as Exdensur rollout and Feb 4 results loom
Next Story

GSK share price dips in London as Exdensur rollout and Feb 4 results loom

Go toTop